Innovotech (CVE:IOT) Stock Price Up 22.7% – Should You Buy?

Innovotech Inc. (CVE:IOTGet Free Report) shares rose 22.7% during mid-day trading on Monday . The stock traded as high as C$0.27 and last traded at C$0.27. Approximately 386,375 shares were traded during trading, an increase of 411% from the average daily volume of 75,557 shares. The stock had previously closed at C$0.22.

Innovotech Stock Performance

The company has a market cap of C$10.92 million, a price-to-earnings ratio of -28.00 and a beta of 1.15. The firm’s 50 day simple moving average is C$0.15 and its 200-day simple moving average is C$0.17. The company has a debt-to-equity ratio of 12.55, a quick ratio of 5.81 and a current ratio of 2.63.

About Innovotech

(Get Free Report)

Innovotech Inc provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; MBEC Assay kit, a petri dish for biofilms, which are used for research and medical device testing of microbial biofilms; and AgreGuard, an antimicrobial for crop protection.

Featured Articles

Receive News & Ratings for Innovotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovotech and related companies with MarketBeat.com's FREE daily email newsletter.